(2S,3R)-3-hydroxy-2-(3-oxo-2-azaspiro[4.5]decan-2-yl)-N-[(3,4,5-trimethoxyphenyl)methyl]butanamide
C23H34N2O6 — CID 139390703
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2S,3R)-3-hydroxy-2-(3-oxo-2-azaspiro[4.5]decan-2-yl)-N-[(3,4,5-trimethoxyphenyl)methyl]butanamide
(2S,3R)-3-hydroxy-2-(3-oxo-2-azaspiro[4.5]decan-2-yl)-N-[(3,4,5-trimethoxyphenyl)methyl]butanamide (PubChem CID 139390703) has the molecular formula C23H34N2O6 and a molecular weight of 434.53 g/mol. Its IUPAC name is (2S,3R)-3-hydroxy-2-(3-oxo-2-azaspiro[4.5]decan-2-yl)-N-[(3,4,5-trimethoxyphenyl)methyl]butanamide.
Molecular Properties
| Compound Name | (2S,3R)-3-hydroxy-2-(3-oxo-2-azaspiro[4.5]decan-2-yl)-N-[(3,4,5-trimethoxyphenyl)methyl]butanamide |
|---|---|
| PubChem CID | 139390703 |
| Molecular Formula | C23H34N2O6 |
| Molecular Weight | 434.53 g/mol |
| Exact Mass | 434.24 |
| IUPAC Name | (2S,3R)-3-hydroxy-2-(3-oxo-2-azaspiro[4.5]decan-2-yl)-N-[(3,4,5-trimethoxyphenyl)methyl]butanamide |
| SMILES | COc1cc(CNC(=O)[C@H]([C@@H](C)O)N2CC3(CCCCC3)CC2=O)cc(OC)c1OC |
| InChI | InChI=1S/C23H34N2O6/c1-15(26)20(25-14-23(12-19(25)27)8-6-5-7-9-23)22(28)24-13-16-10-17(29-2)21(31-4)18(11-16)30-3/h10-11,15,20,26H,5-9,12-14H2,1-4H3,(H,24,28)/t15-,20+/m1/s1 |
| InChIKey | JBMXDNKZORQOBJ-QRWLVFNGSA-N |
| XLogP | 2.26 |
| TPSA | 97.33 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 434.53 |
| LogP ≤ 5 | 2.26 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 139390703 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.